Does RISANKIZUMAB-RZAA Cause Staphylococcal infection? 176 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 176 reports of Staphylococcal infection have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
176
Reports of Staphylococcal infection with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
2
Deaths
100
Hospitalizations
How Dangerous Is Staphylococcal infection From RISANKIZUMAB-RZAA?
Of the 176 reports, 2 (1.1%) resulted in death, 100 (56.8%) required hospitalization.
Is Staphylococcal infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 176 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Staphylococcal infection?
ADALIMUMAB (1,727)
METHOTREXATE (932)
PREDNISONE (914)
ETANERCEPT (850)
TACROLIMUS (777)
MYCOPHENOLATE MOFETIL (677)
CYCLOPHOSPHAMIDE (625)
RITUXIMAB (582)
INFLIXIMAB (561)
SECUKINUMAB (525)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Staphylococcal infection Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA